Copyright
        ©The Author(s) 2022.
    
    
        World J Biol Chem. Mar 27, 2022; 13(2): 47-65
Published online Mar 27, 2022. doi: 10.4331/wjbc.v13.i2.47
Published online Mar 27, 2022. doi: 10.4331/wjbc.v13.i2.47
            Table 1 Primer sequences used in the current study
        
    | Gene | Forward | Reverse | Size | 
| HLA-G1 | AGGAGACACGGAACACCAAG | CCAGCAACGATACCCATGAT | 685 | 
| HLA-G5 | AACCCTCTTCCTGCTGCTCT | GCCTCCATCTCCCTCCTTAC | 895 | 
| HLA-G7 | AACCCTCTTCCTGCTGCTCT | TTACTCACTGGCCTCGCTCT | 331 | 
| GAPDH | AAGGGCCCTGACAACTCTTT | CTCCCCTCTTCAAGGGGTCT | 244 | 
- Citation: Mallis P, Chatzistamatiou T, Dimou Z, Sarri EF, Georgiou E, Salagianni M, Triantafyllia V, Andreakos E, Stavropoulos-Giokas C, Michalopoulos E. Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results. World J Biol Chem 2022; 13(2): 47-65
 - URL: https://www.wjgnet.com/1949-8454/full/v13/i2/47.htm
 - DOI: https://dx.doi.org/10.4331/wjbc.v13.i2.47
 
